Recombinant Bcl2 Antibody
Expression of Bcl-2 alpha oncoprotein inhibits the programmed cell death (apoptosis) . In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 alpha protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies.
Product Specifications
CAS Number
9000-83-3
Specifications
Flow cytometry: 1-2ug/10^6 cells, Immunofluorescence: 1-2 µg/mL, Western blot: 1-2 µg/mL, Immunohistochemistry (FFPE) : 1-2 µg/mL for 30 min at RT
UniProt
P10415
Host
Mouse
Reactivity
Human
Immunogen
Recombinant full-length human protein was used as the immunogen for the recombinant Bcl2 antibody.
Clonality
Recombinant Monoclonal
Isotype
IgG1 k
Clone
RBCL2/782
Type
Recombinant
Applications
FACS, IF, WB, IHC-P
Purity
Protein G affinity chromatography
Format
Purified
Buffer
0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide
Reconstitution
Store the recombinant Bcl2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Limitations
This recombinant Bcl2 antibody is available for research use only.
Storage Conditions
Store the recombinant Bcl2 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide) .
Formulation
0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05% sodium azide
Location
Cytoplasmic, membrane
Documents
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
UBE2H (Ubiquitin-conjugating Enzyme E2 H, UbcH2, Ubiquitin Carrier Protein H, UBCH, Ubiquitin-conjugating Enzyme E2-20K, Ubiquitin-protein Ligase H) (PE)
Lentiviral human ERAL1 shRNA (UAS) - Lentiviral human ERAL1 shRNA (UAS, RFP) (25)
